Document is current
Any future updates will be listed below
-
Authors
Müller, Marion https://orcid.org/0000-0002-8519-0661
Schubert, Torben
Welke, Cornelius https://orcid.org/0000-0001-8496-2853
Maske, Tibor https://orcid.org/0009-0006-3258-8621
Patschkowski, Thomas
Donhauser, Elfi
Heinen-Weiler, Jacqueline
Hormann, Felix-Levin https://orcid.org/0009-0006-3784-6124
Heiles, Sven https://orcid.org/0000-0003-3779-8071
Schulz, Tina Johanna
Lengenfelder, Luisa Andrea
Landwehrjohann, Lucia
Vogt, Elisa Theres
Stratmann, Bernd https://orcid.org/0000-0001-5777-3715
Hense, Jurek https://orcid.org/0009-0002-9183-0052
Lüdtke, Simon
Düfer, Martina https://orcid.org/0000-0003-1572-9235
Tolstik, Elena
Dierks, Johann
Lorenz, Kristina https://orcid.org/0000-0002-5747-2207
Huxohl, Tamino https://orcid.org/0000-0001-8865-2895
Reil, Jan-Christian
Sequeira, Vasco https://orcid.org/0000-0002-9192-7674
Schopfer, Francisco Jose https://orcid.org/0000-0001-9526-695X
Freeman, Bruce A. https://orcid.org/0000-0002-2028-8369
Rudolph, Volker https://orcid.org/0000-0001-5385-6839
Schlomann, Uwe
Klinke, Anna https://orcid.org/0000-0002-1118-4082
- License Information
-
More Information
Article History
Received: 6 February 2024
Accepted: 14 April 2025
First Online: 26 April 2025
Competing interests
: BAF acknowledges an interest in Creegh Pharmaceuticals, Inc., and FJS acknowledges an interest in Creegh Pharmaceuticals, Inc. and Furanica, Inc. The other authors declare no conflict of interest.
